WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Stock Ownership - Who owns Crispr Therapeutics Ag?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crispr Therapeutics Ag insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Samarth KulkarniChief Executive Officer2026-01-2260,000$60.23
$3.61MSell
Raju PrasadChief Financial Officer2026-01-2234,972$60.19
$2.10MSell
Raju PrasadChief Financial Officer2026-01-2234,972$45.15
$1.58MBuy
Samarth KulkarniChief Executive Officer2026-01-2021,433$51.61
$1.11MSell
Samarth KulkarniChief Executive Officer2026-01-208,567$52.10
$446.34kSell
Raju PrasadChief Financial Officer2026-01-0618,933$60.18
$1.14MSell
Raju PrasadChief Financial Officer2026-01-066,339$44.31
$280.88kBuy
Raju PrasadChief Financial Officer2026-01-0623,361$45.15
$1.05MBuy
Raju PrasadChief Financial Officer2026-01-065,763$60.21
$347.01kSell
Raju PrasadChief Financial Officer2026-01-065,004$60.00
$300.24kSell

1 of 5

CRSP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRSP insiders and whales buy or sell their stock.

CRSP Shareholders

What type of owners hold Crispr Therapeutics Ag stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC10.27%9,786,973$488.96MInstitution
Celgene Corp8.98%8,557,514$427.53MInsider
Blackrock Inc7.40%7,050,145$352.23MInstitution
Capital International Investors5.93%5,649,258$282.24MInstitution
Vertex Pharmaceuticals Europe Ltd5.65%5,380,940$268.83MInsider
Simeon George5.52%5,259,390$262.76MInsider
Bayer Global Investments Bv5.36%5,105,330$255.06MInsider
Orbis Allan Gray Ltd5.23%4,982,085$248.90MInstitution
State Street Corp4.20%4,007,233$200.20MInstitution
T Rowe Price Investment Management Inc3.44%3,282,584$164.00MInstitution

1 of 3

CRSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRSP67.81%32.19%Net BuyingNet Selling
CRNX89.33%10.67%Net BuyingNet Buying
TGTX57.07%42.93%Net SellingNet Selling
IMVT44.51%55.49%Net BuyingNet Buying
SRRK62.19%37.81%Net BuyingNet Buying
View Top Biotech Stocks

Crispr Therapeutics Ag Stock Ownership FAQ

Who owns Crispr Therapeutics Ag?

Crispr Therapeutics Ag (NASDAQ: CRSP) is owned by 75.78% institutional shareholders, 35.98% Crispr Therapeutics Ag insiders, and 0.00% retail investors. Celgene Corp is the largest individual Crispr Therapeutics Ag shareholder, owning 8.56M shares representing 8.98% of the company. Celgene Corp's Crispr Therapeutics Ag shares are currently valued at $427.53M.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.